Fator3 Ventures
Fator3 Ventures is a venture capital firm based in São Paulo, Brazil. This profile covers what we know about Fator3 Ventures and how founders can get in front of it in 2026.
Fator3 Ventures is an investment and accelerator firm for startups.
- Location
- São Paulo, Brazil
- Team size
- 11-50
- Portfolio companies
- 1+
How to pitch Fator3 Ventures
The founders who hear back from Fator3 Ventures lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Fator3 Ventures
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Fator3 Ventures." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/fator3-ventures
Frequently Asked Questions
What is Fator3 Ventures?
Fator3 Ventures is a venture capital firm based in São Paulo, Brazil. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Fator3 Ventures based?
Fator3 Ventures is based in São Paulo, Brazil. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Fator3 Ventures?
Unlock a verified email for Fator3 Ventures and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.